Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
Authors
Keywords
-
Journal
Cancer Prevention Research
Volume 16, Issue 11, Pages 621-629
Publisher
American Association for Cancer Research (AACR)
Online
2023-09-27
DOI
10.1158/1940-6207.capr-23-0111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer
- (2022) Joanna Aldoori et al. GUT
- Aspirin Use to Prevent Cardiovascular Disease
- (2022) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines
- (2020) Matthew D Rutter et al. GUT
- A solution to minimum sample size for regressions
- (2020) David G. Jenkins et al. PLoS One
- Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies
- (2020) Rami M. Elshazli et al. GENE
- Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: a Randomized Clinical Trial
- (2020) David A. Drew et al. Cancer Prevention Research
- Aspirin in the Prevention of Colorectal Neoplasia
- (2020) David A. Drew et al. Annual Review of Medicine
- Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial
- (2018) Mark A Hull et al. LANCET
- Colorectal Adenomas
- (2016) Williamson B. Strum NEW ENGLAND JOURNAL OF MEDICINE
- Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas
- (2015) Zahra Montazeri et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants
- (2015) Hongmei Nan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Eicosapentaenoic Acid on E-type Prostaglandin Synthesis and EP4 Receptor Signaling Human Colorectal Cancer Cells
- (2015) Gillian Hawcroft et al. NEOPLASIA
- Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry
- (2014) Alexa J. Resler et al. CARCINOGENESIS
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of 15-Hydroxyprostaglandin Dehydrogenase (HPGD)
- (2014) S. P. Fink et al. Science Translational Medicine
- Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia
- (2013) Sarah E. Kleinstein et al. GENES CHROMOSOMES & CANCER
- Aspirin Use, 8q24 Single Nucleotide Polymorphism rs6983267, and Colorectal Cancer According to CTNNB1 Alterations
- (2013) Hongmei Nan et al. JNCI-Journal of the National Cancer Institute
- A Meta-Analysis of PTGS1 and PTGS2 Polymorphisms and NSAID Intake on the Risk of Developing Cancer
- (2013) Mai Nagao et al. PLoS One
- A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial
- (2013) Mark A Hull et al. Trials
- Aspirin-Intolerant Asthma: A Comprehensive Review of Biomarkers and Pathophysiology
- (2012) Juan R. Velazquez et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer
- (2012) A. Naccarati et al. MUTAGENESIS
- TP53 Arg72Pro Polymorphism and Colorectal Cancer Risk: A Systematic Review and Meta-Analysis
- (2010) I. J. Dahabreh et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence--Data from a Randomized Clinical Trial
- (2009) E. L. Barry et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostate Cancer Risk
- (2009) V. Fradet et al. CLINICAL CANCER RESEARCH
- A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia
- (2008) J T Cross et al. PHARMACOGENOMICS JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started